Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 8,164 | 10,429 | 11,342 | 15,665 | 8,004 |
| Cost of Goods | 1,928 | 1,488 | 1,403 | 1,573 | 793 |
| Gross Profit | 6,236 | 8,941 | 9,939 | 14,092 | 7,211 |
| Operating Expenses | 21,217 | 21,397 | 22,617 | 22,761 | 21,956 |
| Operating Income | -14,053 | -11,968 | -12,275 | -8,096 | -13,952 |
| Other Income | 2,496 | 2,593 | 2,749 | 2,818 | 2,701 |
| Pre-tax Income | -11,557 | -9,375 | -9,526 | -5,278 | -11,251 |
| Net Income Continuous | -11,557 | -9,375 | -9,526 | -5,278 | -11,251 |
| Net Income | $-11,557 | $-9,375 | $-9,526 | $-5,278 | $-11,251 |
| EPS Basic Total Ops | -0.11 | -0.09 | -0.09 | -0.05 | -0.11 |
| EPS Basic Continuous Ops | -0.11 | -0.09 | -0.09 | -0.05 | -0.11 |
| EPS Diluted Total Ops | -0.11 | -0.09 | -0.09 | -0.05 | -0.11 |
| EPS Diluted Continuous Ops | -0.11 | -0.09 | -0.09 | -0.05 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -0.11 | -0.09 | -0.09 | -0.05 | N/A |
| EBITDA(a) | $-14,374 | $-12,569 | $-13,147 | $-8,991 | $-14,353 |